Ursprung des Netzwerks ersten Grades von Daniel Feig
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
XORTX Pharma Corp.
XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Daniel Feig
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
XORTX THERAPEUTICS INC. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
TRILLIUM THERAPEUTICS | Biotechnology | Founder | |
University of Calgary | College/University | Doctorate Degree | |
CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MANY BRIGHT IDEAS TECHNOLOGIES INC. | Medical/Nursing Services | Comptroller/Controller/Auditor | |
BMO Capital Partners
BMO Capital Partners Investment ManagersFinance BMO Capital Partners (BMO Capital) is a private equity subsidiary of BMO Equity Partners Inc. founded in 1996. The firm is headquartered in Toronto, Canada. | Investment Managers | Director/Board Member | |
Clarkson University | College/University | Masters Business Admin | |
Veracyte SD, Inc.
Veracyte SD, Inc. Miscellaneous Commercial ServicesCommercial Services Decipher Biosciences, Inc. is a commercial-stage precision oncology company which engages in patient care improvement. The Company?s differentiated approach measures the biological activity of a patient?s entire tumor genome, known as whole transcriptome analysis, and applies proprietary machine learning algorithms to improve therapy selection and accelerate adoption of new therapies into the standard of care. Its novel prostate cancer genomic testing products examine the underlying biology of a patient?s tumor, enabling physicians to select an optimal therapy. The firm?s whole transcriptome analysis of clinical patient samples from its commercial channel and its participation in practice-changing clinical trials has allowed it to build and expand its Decipher GRID database GRID. The company was founded by Elai Davicioni, Timothy J. Triche, Bruce A. Schmidt, and Jonathan D. Buckley and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Aspreva Pharmaceuticals SA | President |
Statistik
International
Kanada | 9 |
Vereinigte Staaten | 4 |
Schweiz | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Health Services | 2 |
Finance | 2 |
Commercial Services | 2 |
Operativ
Director of Finance/CFO | 6 |
President | 3 |
Director/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Founder | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
David G. Matthews | 10 |
Allen Davidoff | 5 |
Henk ter Keurs | 1 |
- Börse
- Insiders
- Daniel Feig
- Unternehmensverbindungen